Effectiveness and safety of MVA-BN vaccination against Mpox in at-risk individuals in the United States (USMVAc) (USMVAC study)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  HealthVerity United States
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Drug dispensing/prescription data

  Other
• Data sources (types), other:
  Closed claims BHI, PS20 (All medical claims and pharmacy data for up to thirty-three thousand (33,000) de-identified patients for the data period covered and PS20: All medical claims for up to sixty-six thousand (66,000) de-identified patients for the data period covered Labcorp and Quest: All monkeypox lab test data for up to eight thousand five hundred (8,500) de-identified patients

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.